戻る Agenda
S5 - Bridging Regulation and Reality: Decentralized Trials for Broader Participation
Session Chair(s)
Kyung-Sang Yu, MD, PHD, MBA
Professor, Department of Clinical Pharmacology,
Seoul National University , Korea, Republic of
Amy (Hyunjoo) Lee, MBA, RPH
Executive Director, Global Clinical Trial Operation
MSD Korea Ltd., Korea, Republic of
Speaker(s)
Jun Gi Hwang, MD, PHD
Chungbuk National University College of Medicine and Hospital, Korea, Republic of
Associate Professor,
Yoonjin Kim
Seoul National University, Korea, Republic of
Department of Clinical Pharmacology and Therapeutics
Mikiko Kubo
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer, Office of Pharmacovigilance I
Yoomin Song
Eli Lilly and Company, Korea, Republic of
Clinical Research Lead
Hyun Bae
MSD Korea, Korea, Republic of
Clinical Research Manager (CRM)
OkSun Im
Boehringer Ingelheim Korea Ltd., Korea, Republic of
Local Head of CD&O, HP
Stella Ha
Gilead Sciences, Korea, Republic of
Sr. Director, Clinical Operations Korea